Lexicon Pharmaceuticals I... (LXRX)
NASDAQ: LXRX
· Real-Time Price · USD
1.24
0.06 (5.08%)
At close: Aug 15, 2025, 3:59 PM
1.24
0.28%
After-hours: Aug 15, 2025, 04:13 PM EDT
Lexicon Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 28.87M | 1.26M | 26.55M | 1.75M | 1.65M | 1.13M | 702K | 162K | 317K | 24K | 28K | 39K | 35K | 37K | 14K | 23K | 234K | 27K |
Cost of Revenue | 209K | 30K | 348K | 71K | 166K | 175K | 217K | 7K | 8K | 112K | 103K | 108K | 107K | 109K | 16.5M | 15.68M | 10.26M | 12.61M |
Gross Profit | 28.66M | 1.23M | 26.21M | 1.68M | 1.48M | 955K | 485K | 155K | 309K | -88K | -75K | -69K | -72K | -72K | -16.48M | -15.66M | -10.02M | -12.58M |
Operating Income | 3.74M | -25.68M | -32.74M | -63.69M | -55.35M | -45.33M | -46.74M | -49.63M | -44.24M | -31.14M | -30.28M | -23.09M | -24.01M | -23.38M | -25.33M | -22.96M | -17.96M | -20.84M |
Interest Income | 1.83M | n/a | 2.83M | 3.44M | 4.14M | 1.88M | 2.4M | 3M | 1.3M | 1.03M | 887K | 572K | 123K | 14K | 14K | 11K | 61K | 48K |
Pretax Income | 3.25M | -25.3M | -33.77M | -64.81M | -53.43M | -48.4M | -48.24M | -50.52M | -44.9M | -31.93M | -30.49M | -23.39M | -24.59M | -23.48M | -25.61M | -23.12M | -18.07M | -20.96M |
Net Income | 3.25M | -25.3M | -33.77M | -64.81M | -53.43M | -48.4M | -48.24M | -50.52M | -44.9M | -30.91M | -30.71M | -23.68M | -25.17M | -23.57M | -25.61M | -23.12M | -18.07M | -20.96M |
Selling & General & Admin | 9.35M | 11.61M | 32.26M | 39.59M | 39.19M | 32.06M | 32.61M | 32.23M | 30.01M | 19.14M | 16.33M | 12.58M | 10.69M | 8.49M | 8.85M | 7.3M | 7.94M | 8.26M |
Research & Development | 15.57M | 15.3M | 26.68M | 25.78M | 17.64M | 14.23M | 14.62M | 17.56M | 14.54M | 12.03M | 13.98M | 10.56M | 13.36M | 14.93M | 16.5M | 15.68M | 10.26M | 12.61M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 112K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 24.92M | 26.91M | 59.09M | 65.37M | 56.84M | 46.29M | 47.22M | 49.79M | 44.55M | 31.17M | 30.31M | 23.13M | 24.04M | 23.42M | 25.34M | 22.98M | 18.19M | 20.87M |
Interest Expense | 2.32M | -1.83M | 3.86M | 4.56M | 2.21M | 4.95M | 5.42M | 3.9M | 1.96M | 1.82M | 1.1M | 864K | 703K | 110K | 295K | 171K | 169K | 167K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -74.09M | 29.67M | n/a | 16.93M | 5.64M | 10.87M | n/a | n/a | 910K | n/a | n/a | n/a |
Cost & Expenses | 25.13M | 26.94M | 59.29M | 65.44M | 57M | 46.46M | 47.44M | 49.79M | 44.56M | 31.17M | 30.31M | 23.13M | 24.04M | 23.42M | 25.34M | 22.98M | 18.19M | 20.87M |
Income Tax Expense | n/a | n/a | -101K | n/a | n/a | 100.72K | -2.98M | n/a | n/a | -1.03M | 216K | 292K | 580K | 96K | -14K | -90K | 19K | 48K |
Shares Outstanding (Basic) | 363.29M | 362.07M | 361.49M | 361.49M | 310.84M | 245.39M | 244.93M | 244.93M | 204.78M | 189.01M | 188.73M | 174.9M | 149.62M | 149.15M | 148.9M | 145.82M | 144.45M | 143.38M |
Shares Outstanding (Diluted) | 363.57M | 362.07M | 361.49M | 361.49M | 310.84M | 245.39M | 244.93M | 244.93M | 204.78M | 189.01M | 188.73M | 174.9M | 149.62M | 149.15M | 148.9M | 145.82M | 144.45M | 143.38M |
EPS (Basic) | 0.01 | -0.07 | -0.09 | -0.18 | -0.17 | -0.2 | -0.2 | -0.21 | -0.22 | -0.16 | -0.16 | -0.14 | -0.17 | -0.16 | -0.17 | -0.16 | -0.13 | -0.15 |
EPS (Diluted) | 0.01 | -0.07 | -0.09 | -0.18 | -0.17 | -0.2 | -0.2 | -0.21 | -0.22 | -0.16 | -0.16 | -0.14 | -0.17 | -0.16 | -0.17 | -0.16 | -0.13 | -0.15 |
EBITDA | 5.75M | -25.68M | -29.78M | -60.12M | -51.08M | -44.45M | -44.19M | -46.48M | -42.8M | -30M | -29.29M | -22.41M | -23.78M | -23.26M | -25.2M | -22.85M | -17.86M | -20.75M |
EBIT | 5.57M | -25.68M | -29.91M | -60.25M | -51.22M | -44.6M | -44.34M | -46.63M | -42.94M | -30.11M | -29.39M | -22.52M | -23.88M | -23.37M | -25.32M | -22.95M | -17.9M | -20.79M |
Depreciation & Amortization | 176K | 176K | 125K | 126K | 139K | 144K | 147K | 151K | 144K | 112K | 103K | 108K | 107K | 109K | 112K | 101K | 42K | 37K |